Singular Genomics Systems, Inc. financial data

Symbol
OMIC on Nasdaq
Industry
Laboratory Analytical Instruments
Location
3010 Science Park Road, San Diego, CA
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.08K % -42.7%
Quick Ratio 78.7 % -35.2%
Debt-to-equity 50.1 % +86.8%
Return On Equity -54.7 % -44.6%
Return On Assets -36.4 % -22.2%
Operating Margin -3.65K % +22.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 2.5M shares -96.6%
Common Stock, Shares, Outstanding 2.49M shares -96.6%
Entity Public Float 49M USD -77.1%
Common Stock, Value, Issued 0 USD -100%
Weighted Average Number of Shares Outstanding, Basic 2.48M shares +2.63%
Weighted Average Number of Shares Outstanding, Diluted 2.48M shares +2.63%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 2.72M USD +27.6%
Cost of Revenue 3.84M USD +75.1%
Research and Development Expense 45.1M USD -6.65%
Operating Income (Loss) -99.5M USD +0.73%
Net Income (Loss) Attributable to Parent -91.9M USD +2.35%
Earnings Per Share, Basic 0.7 USD/shares +19%
Earnings Per Share, Diluted 0.7 USD/shares +19%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 30.1M USD -59.7%
Cash, Cash Equivalents, and Short-term Investments 133M USD -35.6%
Inventory, Net 12.4M USD -13.3%
Assets, Current 149M USD -34.1%
Property, Plant and Equipment, Net 13.2M USD +15.3%
Operating Lease, Right-of-Use Asset 56.4M USD +28.5%
Other Assets, Noncurrent 1.08M USD -11.9%
Assets 220M USD -22.5%
Accounts Payable, Current 1.5M USD -24.1%
Accrued Liabilities, Current 4.05M USD -2.36%
Liabilities, Current 16.9M USD +21.5%
Operating Lease, Liability, Noncurrent 58.4M USD +43.6%
Other Liabilities, Noncurrent 624K USD -26.9%
Liabilities 82.3M USD +25.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax -74K USD +77.4%
Retained Earnings (Accumulated Deficit) -384M USD -31.5%
Stockholders' Equity Attributable to Parent 138M USD -36.9%
Liabilities and Equity 220M USD -22.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -23.7M USD -32.2%
Net Cash Provided by (Used in) Financing Activities 0 USD -100%
Net Cash Provided by (Used in) Investing Activities 31.6M USD -56.7%
Common Stock, Shares Authorized 400M shares 0%
Common Stock, Shares, Issued 2.49M shares
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 7.88M USD -85.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 30.7M USD -59.9%
Interest Paid, Excluding Capitalized Interest, Operating Activities 246K USD +13.9%
Deferred Tax Assets, Valuation Allowance 86.2M USD +45%
Deferred Tax Assets, Gross 102M USD +40.4%
Operating Lease, Liability 65.4M USD +35.6%
Depreciation 1.02M USD +28.5%
Payments to Acquire Property, Plant, and Equipment 25K USD -84.6%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -91.6M USD +1.91%
Lessee, Operating Lease, Liability, to be Paid 115M USD +36.7%
Property, Plant and Equipment, Gross 23.3M USD +31.8%
Operating Lease, Liability, Current 7.07M USD -7.13%
Lessee, Operating Lease, Liability, to be Paid, Year Two 5.72M USD +2.81%
Lessee, Operating Lease, Liability, to be Paid, Year One 4.11M USD -47.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure +11%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 179M USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Three 8.61M USD +54.7%
Deferred Tax Assets, Operating Loss Carryforwards 54.3M USD +35.3%
Unrecognized Tax Benefits 2.22M USD +79.7%
Lessee, Operating Lease, Liability, to be Paid, Year Four 8.58M USD +57.5%
Additional Paid in Capital 522M USD +2.15%
Deferred Tax Assets, Net of Valuation Allowance 15.7M USD +19.5%
Share-based Payment Arrangement, Expense 11.2M USD -14.9%
Interest Expense 1.14M USD +16.2%